There is evidence of risk with the use of selective serotonin reuptake inhibitors (SSRIs) during pregnancy and to neonatal health and beyond, according to a study published in Human Reproduction.

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!

SSRIs risky during pregnancy and affect neonatal health

Newsletter